BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Z, Chen Y, Niu B, Yin D, Feng F, Gu S, An Q, Xu J, An N, Zhang J, Yi J, Yin W, Qin X, Hu X. NLRP3 inflammasome of renal tubular epithelial cells induces kidney injury in acute hemolytic transfusion reactions. Clin Transl Med 2021;11:e373. [PMID: 33783986 DOI: 10.1002/ctm2.373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ying C, Zhou Z, Dai J, Wang M, Xiang J, Sun D, Zhou X. Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy. Inflamm Res 2022. [PMID: 35028708 DOI: 10.1007/s00011-021-01532-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu W, Han X, Li Q, Sun L, Wang J. Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation. Biomedicine & Pharmacotherapy 2022;153:113460. [DOI: 10.1016/j.biopha.2022.113460] [Reference Citation Analysis]
3 Su Y, Hu L, Wang Y, Ying G, Ma C, Wei J. The Rho kinase signaling pathway participates in tubular mitochondrial oxidative injury and apoptosis in uric acid nephropathy. J Int Med Res 2021;49:3000605211021752. [PMID: 34167354 DOI: 10.1177/03000605211021752] [Reference Citation Analysis]
4 Jin J, Zhou TJ, Ren GL, Cai L, Meng XM. Novel insights into NOD-like receptors in renal diseases. Acta Pharmacol Sin 2022. [PMID: 35365780 DOI: 10.1038/s41401-022-00886-7] [Reference Citation Analysis]